OTCM
SWSDF
Market cap31bUSD
, Last price
Name
Swiss Life Holding AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Headquartered in Zurich, Switzerland, and established in 1857, Swiss Life Holding AG offers a broad spectrum of financial services, including life insurance, pension provisions, and risk management solutions for both private individuals and corporate entities. The company operates through distinct segments encompassing Switzerland, France, Germany, its International division, and Asset Managers. Its product portfolio extends to various life, health, annuity, and investment-linked insurance policies for groups and individuals, complemented by disability coverage. Beyond life-related offerings, Swiss Life also underwrites property, casualty, liability, motor, and accident insurance. The firm additionally provides asset management and advisory services tailored for institutional clients. Diversifying its business, Swiss Life Holding AG also has stakes in private equity, information technology, real estate, banking, restaurant, and investment fund ventures. Distribution of its products occurs via a robust network of agents, financial advisors, and partners, with its international presence marked by brands such as Swiss Life Select, Tecis, Horbach, Proventus, Chase de Vere, and Fincentrum.
Related entities
Subsidiaries (47)
aXenta AG
PATRIMONY INVESTMENTS
SOC CIV SAINTE AURELIA
SWISS LIFE (LIECHTENSTEIN) AG
Swiss Life AG
Swiss Life AG - Reinsurance Account (RE)
Swiss Life AG - Separate account individual life (EV)
Swiss Life AG General Account (NZ)
Swiss Life AG Separate Account Group Life (KV)
Swiss Life Asset Managers Deutschland GmbH
SWISS LIFE ASSURANCE SOLUTIONS S.A.
Swiss Life Deutschland Holding GmbH
SWISS LIFE FINANCE I AG
Swiss Life Investment Management Holding AG
Swiss Life Kapitalverwaltungsgesellschaft mbH
Swiss Life Select Osterreich GmbH
AZUR FINANCES INVEST
Best Solution Funds SICAV, a.s.
CAR 3001
CHASE DE VERE INDEPENDENT FINANCIAL ADVISERS LIMITED
Key people
Matthias Aellig
Group Chief Executive Officer, Member of the Corporate Executive Board · since 2024
Marco Gerussi
Group Chief Financial Officer, Members of the Corporate Executive Board · since 2024
Per Erikson
Group Chief Investment Officer, Member of the Corporate Executive Board · since 2025
Theo Iaponas
Chief Executive Officer - International, Member of the Corporate Executive Board · since 2023
Group Chief Investment Officer, Member of the Corporate Executive Board · since 2014
Tanguy Polet
Chief Executive Officer, France, Member of the Corporate Executive Board · since 2021
Roman Stein
Chief Executive Officer, Switzerland, Member of the Corporate Executive Board · since 2024
Dirk von der Crone
Chief Executive Officer, Germany, Member of the Corporate Executive Board · since 2024
Member of the Board of Directors · since 2019
Philomena Colatrella
Independent Member of the Board of Directors · since 2023
Monika Buetler
Independent Member of the Board of Directors · since 2022
Rolf Doerig
Independent Chairman of the Board of Directors · since 2009
Damir Filipovic
Independent Member of the Board of Directors · since 2011
Adrienne Fumagalli
Independent Member of the Board of Directors · since 2014
Stefan Loacker
Independent Member of the Board of Directors · since 2017
Severin Moser
Independent Member of the Board of Directors · since 2023
Independent Member of the Board of Directors · since 2006
Franziska Sauber
Independent Member of the Board of Directors · since 2003
Independent Member of the Board of Directors · since 2018
Klaus Tschuetscher
Independent Vice Chairman of the Board · since 2021
Legal address
C/O Swiss Life AG
General-Guisan-Quai 40
Zurich, ZH 8002
CH
General-Guisan-Quai 40
Zurich, ZH 8002
CH
Headquarters
General-Guisan-Quai 40
Zurich, ZH 8002
CH
Zurich, ZH 8002
CH
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||